135 related articles for article (PubMed ID: 16928814)
1. A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity.
Law B; Quinti L; Choi Y; Weissleder R; Tung CH
Mol Cancer Ther; 2006 Aug; 5(8):1944-9. PubMed ID: 16928814
[TBL] [Abstract][Full Text] [Related]
2. Potential-dependent membrane permeabilization and mitochondrial aggregation caused by anticancer polyarginine-KLA peptides.
Lemeshko VV
Arch Biochem Biophys; 2010 Jan; 493(2):213-20. PubMed ID: 19900399
[TBL] [Abstract][Full Text] [Related]
3. Tumor targeting and microenvironment-responsive multifunctional fusion protein for pro-apoptotic peptide delivery.
Yin J; Liu D; Bao L; Wang Q; Chen Y; Hou S; Yue Y; Yao W; Gao X
Cancer Lett; 2019 Jun; 452():38-50. PubMed ID: 30904618
[TBL] [Abstract][Full Text] [Related]
4. Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy.
Huang Y; Li X; Sha H; Zhang L; Bian X; Han X; Liu B
Oncol Rep; 2017 Apr; 37(4):2063-2070. PubMed ID: 28260064
[TBL] [Abstract][Full Text] [Related]
5. Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12.
Sun W; Li L; Li LJ; Yang QQ; Zhang ZR; Huang Y
Acta Pharmacol Sin; 2017 Jun; 38(6):806-822. PubMed ID: 28065935
[TBL] [Abstract][Full Text] [Related]
6. Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy.
Jung HK; Kim S; Park RW; Park JY; Kim IS; Lee B
J Control Release; 2016 Aug; 235():259-267. PubMed ID: 27282414
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity.
Hao W; Hu C; Huang Y; Chen Y
PLoS One; 2019; 14(11):e0223738. PubMed ID: 31703065
[TBL] [Abstract][Full Text] [Related]
8. The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH.
Kim HY; Kim S; Youn H; Chung JK; Shin DH; Lee K
Biomaterials; 2011 Aug; 32(22):5262-8. PubMed ID: 21565400
[TBL] [Abstract][Full Text] [Related]
9. Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity.
Chu DS; Bocek MJ; Shi J; Ta A; Ngambenjawong C; Rostomily RC; Pun SH
J Control Release; 2015 May; 205():155-61. PubMed ID: 25596326
[TBL] [Abstract][Full Text] [Related]
10. Selective apoptotic killing of solid and hematologic tumor cells by bombesin-targeted delivery of mitochondria-disrupting peptides.
Cai H; Yang H; Xiang B; Li S; Liu S; Wan L; Zhang J; Li Y; Cheng J; Lu X
Mol Pharm; 2010 Apr; 7(2):586-96. PubMed ID: 20141196
[TBL] [Abstract][Full Text] [Related]
11. Chondroitin sulfate as a molecular portal that preferentially mediates the apoptotic killing of tumor cells by penetratin-directed mitochondria-disrupting peptides.
Yang H; Liu S; Cai H; Wan L; Li S; Li Y; Cheng J; Lu X
J Biol Chem; 2010 Aug; 285(33):25666-76. PubMed ID: 20484051
[TBL] [Abstract][Full Text] [Related]
12. An in-tether chiral center modulates the proapoptotic activity of the KLA peptide.
Li J; Hu K; Chen H; Wu Y; Chen L; Yin F; Tian Y; Li Z
Chem Commun (Camb); 2017 Sep; 53(75):10452-10455. PubMed ID: 28884757
[TBL] [Abstract][Full Text] [Related]
13. A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth.
Alves ID; Carré M; Montero MP; Castano S; Lecomte S; Marquant R; Lecorché P; Burlina F; Schatz C; Sagan S; Chassaing G; Braguer D; Lavielle S
Biochim Biophys Acta; 2014 Aug; 1838(8):2087-98. PubMed ID: 24796502
[TBL] [Abstract][Full Text] [Related]
14. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
[TBL] [Abstract][Full Text] [Related]
15. iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice.
Qifan W; Fen N; Ying X; Xinwei F; Jun D; Ge Z
Tumour Biol; 2016 Aug; 37(8):10643-52. PubMed ID: 26867766
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.
Fu B; Long W; Zhang Y; Zhang A; Miao F; Shen Y; Pan N; Gan G; Nie F; He Y; Zhang J; Teng G
Sci Rep; 2015 Jan; 5():8029. PubMed ID: 25619721
[TBL] [Abstract][Full Text] [Related]
17. Smart pH-Sensitive Nanogels for Enhancing Synergistic Anticancer Effects of Integrin α
Xu Y; Sun L; Feng S; Chen J; Gao Y; Guo L; An X; Nie Y; Zhang Y; Liu X; Ning X
ACS Appl Mater Interfaces; 2019 Sep; 11(38):34663-34675. PubMed ID: 31490654
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of the pro-apoptosis peptide kla-TAT and the cationic anticancer peptide HPRP-A1.
Hu C; Chen X; Huang Y; Chen Y
Apoptosis; 2018 Feb; 23(2):132-142. PubMed ID: 29397453
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a catalytic nanomaterial from polypyrrole and a pro-apoptotic peptide to target mitochondria for multimodal cancer therapy.
Wang C; Tian X; Li X
Org Biomol Chem; 2024 Jun; 22(24):4958-4967. PubMed ID: 38819437
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.
Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH
J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
